Drug induced nightmares—an etiology based review

Human Psychopharmacology - Tập 18 Số 1 - Trang 59-67 - 2003
J.F. Pagel1, P. Helfter2
1Parkview Neurological Institute, University of Colorado Medical School, 1619 North Greenwood, Pueblo, Colorado 81003, USA.
2Parkview Episcopal Medical Center, 400 W. 16th Street, Pueblo, Colorado 81003, USA

Tóm tắt

AbstractObjectiveRecent clinical trials have included patient complaints of nightmares as a category of reportable medication side effects. This study integrates that data into current experimental and theoretical research of drug effects that may alter dreaming and nightmares. The objective is to provide a clinical and theoretical framework useful in categorizing the potential and reported drug effects on nightmares.MethodologyThis study reviews case reports and clinical trials that have reported nightmares or alterations in dreaming occurring secondary to medication usage. These data are analysed as to the probability of the drug/nightmare association, and integrated into current electrophysiological and neurochemical theories of dreaming and nightmares.ResultsPharmacological agents affecting the neurotransmitters norepinephrine, serotonin and dopamine are clearly associated with patient reports of nightmares. Agents affecting immunological response to infectious disease are likely to induce nightmares in some patients. A possible association exists between reports of nightmares and agents affecting the neurotransmitters acetylcholine, GABA and histamine, as well as for some anesthetics, antipsychotics and antiepileptic agents.ConclusionBy utilizing our current experimental and theoretical knowledge base, the potential etiology of a majority of reported drug effects on nightmares can be classified. These data support current neurochemical theories of dreaming, as well as suggesting that the biochemical basis for dreaming and nightmare induction may be more complex than generally suggested. Copyright © 2003 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Ansoms A, 1991, Zopiclone or lometazepam in the treatment of insomnia and the effect on behavior and mood during the post‐alcoholism withdrawal period, Curr Ther Res, 49, 54

10.1097/00005053-196812000-00006

10.1176/ajp.136.10.1257

10.1111/j.0954-6820.1987.tb01260.x

Cohen DB, 1979, Sleep and Dreaming: Origins, Nature and Function

10.1097/00004714-199610000-00003

10.1016/0022-3999(92)90087-I

10.1097/00005053-199702000-00006

10.1002/jts.2490100109

Foulkes D, 1985, Dreaming: A Cognitive‐Psychological Analysis

Francis A, 1994, DSM‐IV—Diagnostic and Statistical Manual of Mental Disorders

10.1016/S0165-1781(96)02942-3

10.1093/hrp/8.6.298

Hobson JA, 1986, Handbook of Psychology, 701

Hobson JA, 1994, The Chemistry of Conscious States

Hobson JA, 1999, Dreaming as Delerium, 10.7551/mitpress/2497.001.0001

Jaffe SE, 2000, Principles and Practice of Sleep Medicine, 1093

Jouvet M, 1999, The Paradox of Sleep: The Story of Dreaming

10.1378/chest.91.4.540

10.1097/00000542-199007000-00009

Krakow B, 1992, Conquering Bad Dreams and Nightmares: A Guide to Understanding, Interpretation and Cure

Krissel J, 1994, Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section, Eur J Anaesthesiol, 11, 115

Krueger JM, 2000, Principles and Practice of Sleep Medicine, 255

Krueger JM, 1986, Enhancement of slow wave sleep by endotoxin and libid A, Am J Physiol, 251, R591

10.1097/00002826-199502000-00013

10.1016/S0306-4522(01)00062-8

Marsh SCU, 1992, Dreaming and anesthesia: total i.v. anaesthesia with propofol versus balanced volatile anaesthesia with enflurane, Eur J Anaesthesiol, 9, 331

10.1176/ajp.139.5.565

McEvoy GK, 2002, AHFS Drug Information, 04

10.1176/ajp.152.1.110

Moffitt A, 1993, The Functions of Dreaming

10.1038/clpt.1981.154

10.1097/00000539-199709000-00013

Pace‐Schott E, 1999, Effects of serotonin reuptake inhibitors (SSRI) on dreaming in normal subjects, Sleep, 22, H278D

Pace‐Schott E, 2000, Enhancement of subjective intensity of dream features in normal subjects by the SSRIs paroxetine and fluvoxamine, Behav Brain Sci, 23, 980

Pace‐SchottEF.Recent findings on the neurobiology of sleep and dreaming. In C.U.P. bookSleep and Dreaming: Scientific Advances and Reconsiderations Based on BBS Special Issue on Sleep and Dreaming(v. 23 December2000).

Pagel JF, 1986, The diagnosis and treatment of insomnia, Am Fam Physic, 35, 191

10.1002/hup.470080307

Pagel JF, 1999, Defining dreaming—a paradigm for comparing interdisciplinary studies of dream, Bull Am Acad Sleep Med, 6, 34

10.1023/A:1012240307661

10.1002/(SICI)1099-1077(199605)11:3<217::AID-HUP790>3.0.CO;2-0

Pagel JF, 2000, Nightmares and disorders of dreaming, Am Family Physic, 61, 2037

10.1006/brcg.1995.1255

10.1176/ajp.146.1.128-a

10.1016/S0733-8619(05)70281-4

Sifton DW, 2002, Physicians' Desk Reference

Solms M, 1997, The Neuropsychology of Dreams—A Clinico‐Anatomical Study

10.1016/S0025-7125(05)70114-0

Terr LC, 1987, Sleep and Its Disorders in Children

10.1345/aph.18150

Thorpy M, 1997, American Sleep Disorders Association, The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual

Van Moffaert M, 1990, Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients, Curr Ther Res, 48, 140

10.1037/0021-843X.99.1.64

10.1152/jn.1999.82.4.2015

10.1176/ajp.152.12.1705

Thông tin
Thông tin xuất bản

Human Psychopharmacology

Tập 18 Số 1

59-67

Thông tin tác giả